ARK GENOMIC REVOLUTION MULTI SECTOR ETF (ARKG) HOLDINGS As of 09/27/2021

Company Ticker CUSIP Shares Market Value($) Weight(%)

1 TELADOC HEALTH INC TDOC 87918A105 3,937,797 531,208,815.30 6.99 2 EXACT SCIENCES CORP EXAS 30063P105 3,971,013 381,296,668.26 5.01 3 PACIFIC BIOSCIENCES OF CALIF PACB 69404D108 13,696,148 350,347,465.84 4.61 4 VERTEX PHARMACEUTICALS INC VRTX 92532F100 1,722,281 316,228,014.41 4.16 5 FATE THERAPEUTICS INC FATE 31189P102 4,825,395 312,926,865.75 4.12 6 IONIS PHARMACEUTICALS INC IONS 462222100 8,572,965 310,341,333.00 4.08 7 REGENERON PHARMACEUTICALS REGN 75886F107 430,742 275,201,063.80 3.62 8 TWIST BIOSCIENCE CORP TWST 90184D100 2,237,350 250,829,308.50 3.30 9 TAKEDA PHARMACEUTIC-SP ADR TAK UN 874060205 13,592,076 229,570,163.64 3.02 10 ACCOLADE INC ACCD 00437E102 5,268,242 226,850,500.52 2.98 11 INTELLIA THERAPEUTICS INC NTLA 45826J105 1,508,421 224,965,907.94 2.96 12 VEEVA SYSTEMS INC-CLASS A VEEV 922475108 741,198 222,307,516.14 2.92 13 CAREDX INC CDNA 14167L103 3,433,475 220,978,451.00 2.91 14 CRISPR THERAPEUTICS AG CRSP H17182108 1,804,041 210,044,493.63 2.76 15 INCYTE CORP INCY 45337C102 2,893,385 199,643,565.00 2.63 16 INVITAE CORP NVTA 46185L103 6,059,066 182,135,523.96 2.40 17 ADAPTIVE BIOTECHNOLOGIES ADPT 00650F109 4,888,391 178,377,387.59 2.35 18 BEAM THERAPEUTICS INC BEAM 07373V105 1,849,698 175,110,909.66 2.30 19 SIGNIFY HEALTH INC -CLASS A SGFY 82671G100 8,107,683 160,937,507.55 2.12 20 UIPATH INC - CLASS A PATH 90364P105 2,955,628 155,761,595.60 2.05 21 CASTLE BIOSCIENCES INC CSTL 14843C105 2,130,211 154,312,484.84 2.03 22 CODEXIS INC CDXS 192005106 5,921,779 151,419,889.03 1.99 23 IOVANCE BIOTHERAPEUTICS INC IOVA 462260100 5,941,379 148,296,819.84 1.95 24 SCHRODINGER INC SDGR 80810D103 2,541,038 147,253,152.10 1.94 25 ARCTURUS THERAPEUTICS HOLDIN ARCT UQ 03969T109 2,544,563 129,034,789.73 1.70 26 GINKGO BIOWORKS HOLDINGS INC DNA 37611X100 9,355,762 117,882,601.20 1.55 27 PERSONALIS INC PSNL 71535D106 5,175,029 101,637,569.56 1.34 28 PFIZER INC PFE 717081103 2,232,656 98,102,904.64 1.29 29 10X GENOMICS INC-CLASS A TXG 88025U109 635,050 97,899,308.00 1.29 30 VERACYTE INC VCYT 92337F107 1,988,462 97,196,022.56 1.28 31 908 DEVICES INC MASS 65443P102 2,680,342 97,510,841.96 1.28 32 QUANTUM-SI INC QSI 74765K105 9,756,089 85,951,144.09 1.13 33 BERKELEY LIGHTS INC BLI 084310101 3,904,528 83,634,989.76 1.10 34 REPARE THERAPEUTICS INC RPTX 760273102 2,986,708 82,522,742.04 1.09 35 BUTTERFLY NETWORK INC BFLY 124155102 7,241,695 82,844,990.80 1.09 36 SEMA4 HOLDINGS CORP SMFR 81663L101 9,676,742 78,962,214.72 1.04 37 1LIFE HEALTHCARE INC ONEM 68269G107 3,613,877 77,517,661.65 1.02 38 EDITAS MEDICINE INC EDIT 28106W103 1,276,014 74,914,781.94 0.99 39 RECURSION PHARMACEUTICALS-A RXRX 75629V104 2,612,259 64,052,590.68 0.84 40 SOMALOGIC INC SLGC 83444K105 4,866,047 62,139,420.19 0.82 41 VERVE THERAPEUTICS INC VERV 92539P101 1,276,133 61,165,054.69 0.80 42 CELLECTIS - ADR CLLS 15117K103 3,884,479 52,090,863.39 0.69 43 ZYMERGEN INC ZY 98985X100 3,807,510 51,020,634.00 0.67 44 PALANTIR TECHNOLOGIES INC-A PLTR 69608A108 1,640,902 46,864,161.12 0.62 45 NANOSTRING TECHNOLOGIES INC NSTG 63009R109 872,609 43,394,845.57 0.57 46 NOVARTIS AG-SPONSORED ADR NVS 66987V109 445,620 36,955,266.60 0.49 47 CERUS CORP CERS 157085101 5,243,005 34,498,972.90 0.45 48 SURFACE ONCOLOGY INC SURF 86877M209 4,284,470 31,705,078.00 0.42 49 AQUABOUNTY TECHNOLOGIES AQB 03842K200 6,274,782 25,789,354.02 0.34 50 COMPUGEN LTD CGEN M25722105 3,678,563 22,880,661.86 0.30 51 DYNAMICS SPECIAL PURPOSE C-A DYNS 268010105 2,301,832 22,742,100.16 0.30 52 CARIBOU BIOSCIENCES INC CRBU 142038108 426,842 10,346,650.08 0.14 53 EVOGENE LTD EVGN M4119S104 2,963,362 8,356,680.84 0.11 54 DREYFUS GOVT CASH MAN INS X9USDDGCM 5,714,009 5,714,009.44 0.08 55 ORGANOVO HOLDINGS INC ONVO 68620A203 246,104 1,730,111.12 0.02 56 BRISTOL-MYERS SQUIBB CO BMY 110122108 612 36,860.76 0.00 57 CM LIFE SCIENCES II -CW27 SLGCW 83444K113 548,744 0.00 0.00

The principal risks of investing in ARK ETFs include equity, market, management and non-diversification risks, as well as fluctuations in market value and net asset value ("NAV"). Investors should carefully consider the investment objectives and risks as well as charges and expenses of an ETF before investing. This and other information are contained in each ETF's prospectus, which may be obtained by contacting the ETF's transfer agent The Bank of New York Mellon or by clicking here. Please read the prospectus carefully before you invest. The market price of ETF shares may differ significantly from their NAV during periods of market volatility. ETF shares may only be redeemed directly with the ETF at NAV by Authorized Participants, in very large creation units. Holdings are subject to change without notice and are not a recommendation to buy or sell any security. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns. ©2021, ARK Investment Management LLC. All content is original and has been researched and produced by ARK Investment Management LLC unless otherwise stated. No part of this content may be reproduced in any form, or referred to in any other publication, without the express written permission of ARK Investment Management LLC. All statements made regarding companies, securities or other financial information on this site or any sites or articles relating to ARK Investment Management LLC are strictly beliefs and points of view held by ARK Investment Management and are subject to change without notice. Information contained herein has been obtained from sources believed to be reliable, but not guaranteed. This material has been distributed for informational purposes only and should not be considered as investment advice or a recommendation of any particular security, strategy or investment product.